STZ - Constellation Brands, Inc.

NYSE - Nasdaq Real Time Price. Currency in USD
189.73
+2.43 (+1.30%)
As of 9:36AM EST. Market open.
Stock chart is not supported by your current browser
Previous Close187.30
Open189.24
Bid188.50 x 800
Ask189.00 x 3100
Day's Range189.20 - 190.38
52 Week Range184.76 - 236.62
Volume85,737
Avg. Volume2,109,792
Market Cap36.033B
Beta (3Y Monthly)-0.01
PE Ratio (TTM)11.36
EPS (TTM)16.70
Earnings DateJan 9, 2019
Forward Dividend & Yield2.96 (1.55%)
Ex-Dividend Date2018-11-05
1y Target Est246.23
Trade prices are not sourced from all markets
  • See what the IHS Markit Score report has to say about Constellation Brands Inc.
    Markit2 hours ago

    See what the IHS Markit Score report has to say about Constellation Brands Inc.

    Constellation Brands Inc NYSE:STZ

  • Altria Grossly Overpaid for Its Equity Stake in Pot Stock Cronos Group
    Motley Fool2 hours ago

    Altria Grossly Overpaid for Its Equity Stake in Pot Stock Cronos Group

    Ponying up $1.8 billion for a 45% stake in Cronos could come back to haunt the maker of Marlboro cigarettes.

  • The Zacks Analyst Blog Highlights: Altria, Cronos, Constellation, Canopy Growth and ETFMG Alternative Harvest
    Zacks5 hours ago

    The Zacks Analyst Blog Highlights: Altria, Cronos, Constellation, Canopy Growth and ETFMG Alternative Harvest

    The Zacks Analyst Blog Highlights: Altria, Cronos, Constellation, Canopy Growth and ETFMG Alternative Harvest

  • InvestorPlace20 hours ago

    4 Reasons Why Aphria Stock Could Be an M&A Target Next

    Despite broader market turmoil, the cannabis sector is starting to heat up again thanks to M&A activity. First it was Canopy Growth (NYSE:CGC), then Cronos (NASDAQ:CRON), and I think the next target is going to be Aphria (NYSE:APHA) stock. Now, everyone is again bidding up pot stocks in an attempt to find the next M&A target, which leads us to Aphria.

  • Zacks16 hours ago

    Cronos Group (CRON) Soars on C$2.4B Investment from Altria

    Cronos Group (CRON) receives a significant boost with C$2.4-billion equity investment from tobacco giant Altria Group.

  • Zacks16 hours ago

    Here's Why You Should Hold Constellation Brands Stock Now

    Constellation Brands (STZ) is a favored stock, owing to its robust surprise trend, strength in the beer business and solid business growth plans, including investment in Canopy Growth.

  • InvestorPlace21 hours ago

    4 Reasons Why Pot Stocks Will Be More Stable In 2019

    If there was one investment that took the financial markets by storm in 2018, it was marijuana stocks. The group, headlined by Canopy Growth (NYSE:CGC), Tilray (NASDAQ:TLRY), Aurora (NYSE:ACB), and Cronos (NASDAQ:CRON), wasn’t well known to investors at the beginning of the year. First, everyone started getting excited in 2018 about the nationwide legalization of cannabis in Canada in October.

  • CNBC17 hours ago

    Top pot analyst says Corona maker Constellation is a best stock idea for 2019

    Since Constellation first announced its $4 billion investment in Canopy Growth, shares have fallen almost 15 percent, a good entry point, Azer says. The cannabis investment is "a strategic long-term investment that should pay dividends as the Canadian adult use market sorts itself out," she added.

  • Cronos-Altria Deal Boost Marijuana ETF: Will This Continue?
    Zacks23 hours ago

    Cronos-Altria Deal Boost Marijuana ETF: Will This Continue?

    Altria investment in Canadian cannabis producer Cronos sparked a rally in the broad cannabis sector and the its ETF. Will the trend continue?

  • 7 Events That Shaped Canopy Growth's 2018
    Motley Foolyesterday

    7 Events That Shaped Canopy Growth's 2018

    This helps to explain why Canopy is the largest marijuana stock by market cap.

  • Is Constellation Brands, Inc. (STZ) A Good Stock According To Hedge Funds?
    Insider Monkey2 days ago

    Is Constellation Brands, Inc. (STZ) A Good Stock According To Hedge Funds?

    After several tireless days we have finished crunching the numbers from the more than 700 13F filings issued by the elite hedge funds and other investment firms that we track at Insider Monkey, which disclosed those firms’ equity portfolios as of September 30. The results of that effort will be put on display in this […]

  • 4 Multibillion-Dollar Industries Canopy Growth Thinks It Will Disrupt
    Motley Fool3 days ago

    4 Multibillion-Dollar Industries Canopy Growth Thinks It Will Disrupt

    Are Canopy's plans to jump into multiple huge markets only pipe dreams? Not at all.

  • Altria Buys a $1.8 Billion Stake in Cronos Group: 3 Things You Need to Know About the Monster Deal
    Motley Fool3 days ago

    Altria Buys a $1.8 Billion Stake in Cronos Group: 3 Things You Need to Know About the Monster Deal

    A Big Tobacco company makes a big bet on marijuana. Here's what it means.

  • InvestorPlace4 days ago

    What Cronos Stock Investors Should Do After the Altria Buyout

    Earlier this week, Cronos (NASDAQ:CRON) put out a press release confirming that tobacco company Altria Group (NYSE:MO) was considering an investment in the company, but that no decision was finalized. Altria announced a massive move into the tobacco space. It decided to make a C$2.4 billion ($1.8 billion) strategic investment into Cronos, confirming the earlier rumors.

  • It's Official: Altria Invests $1.8 Billion in This Top Marijuana Stock
    Motley Fool4 days ago

    It's Official: Altria Invests $1.8 Billion in This Top Marijuana Stock

    The company behind Marlboro is taking nearly a 50% equity stake in Canadian pot stock Cronos Group.

  • This Small-Cap Pot Stock Just Paid $85 Million to Expand the Reach of Its CBD Beverages
    Motley Fool4 days ago

    This Small-Cap Pot Stock Just Paid $85 Million to Expand the Reach of Its CBD Beverages

    The market for CBD products is about to explode, but keep in mind that not everyone will be a winner.

  • MarketWatch4 days ago

    Altria to invest C$2.4 billion in Canadian cannabis company Cronos

    Canadian cannabis company Cronos Group Inc. said Friday that tobacco giant Altria Group Inc. has agreed to make a C$2.4 billion ($1.8 billion) equity investment in the company to provide the capital to help it expand and innovate. As part of the deal, Altria will receive warrants that if fully exercised would grant the company an additional C$1.4 billion. Altria will have a roughly 45% ownership stake in the company that would climb to 55% if the warrants are exercised. "This strategic partnership provides Cronos Group with additional financial resources, product development and commercialization capabilities, and deep regulatory expertise to better position the Company to compete, scale and lead the rapidly growing global cannabis industry," Cronos said in a statement. The new legal Canadian cannabis market is attracting investment from a range of players, including a $4 billion investment from Constellation Brands Inc. in Canopy Growth Corp. . Cronos will be Altria's exclusive partner in pursuing opportunities in the sector, said the statement. The deal is expected to close in the first half of 2019. Altria shares rose 1.1% premarket. Cronos shares were halted for the news, but have gained 35% in 2018, while the S&P 500 has gained 0.8%.

  • Motley Fool5 days ago

    3 Top Marijuana Stocks to Watch in December

    Are there profits still to be had in this smoking-hot sector?

  • The Wall Street Journal5 days ago

    [$$] Beverage Company Devotes $100 Million to Female-led Startups

    The corporate venture capital arm of Constellation, an international producer and marketer of alcoholic beverages such as Corona and Robert Mondavi, said Thursday it plans to invest $100 million over the next 10 years into startups founded or led by women. The New York-based company has invested in two such startups so far: a bottled cocktail company called Austin Cocktails Investments LLC and Vivify Beverages, which specializes in drinks for people with dietary restrictions like gluten. No financial terms were disclosed.

  • Corona Maker Invests $100 Million to Boost Female Entrepreneurs
    Bloomberg5 days ago

    Corona Maker Invests $100 Million to Boost Female Entrepreneurs

    (Bloomberg) -- Constellation Brands Inc., maker of Corona beer for the U.S. and Svedka vodka, will invest $100 million in female-founded alcoholic beverage companies over the next 10 years in an effort to support women in the male-dominated liquor and beer industry.

  • GlobeNewswire5 days ago

    Constellation Brands to Invest $100 Million in Women-Led Start-Ups by 2028

    Constellation Brands, Inc. (NYSE:STZ and STZ.B), a leading beverage alcohol company, announced today that Constellation Brands Ventures (CBV), the company’s corporate venture capital group, intends to invest $100 million in female-founded or female-led businesses in the beverage alcohol space and adjacent categories by 2028 through a new program, Focus on Female Founders. “Our Focus on Female Founders program reinforces our commitment to supporting the advancement of women within our company, within our industry, and in our local communities,” said Mallika Monteiro, chief growth officer, Constellation Brands. “This program is designed to make meaningful investments in female-founded and female-led businesses doing disruptive and innovative work across beverage alcohol.

  • PepsiCo (PEP) Acquires SodaStream, Expands Beverage Portfolio
    Zacks5 days ago

    PepsiCo (PEP) Acquires SodaStream, Expands Beverage Portfolio

    PepsiCo (PEP) closes the acquisition of SodaStream for $3.2 billion. This should fortify PepsiCo's beverage and fast-growing water portfolio alongside adding at-home refreshment beverage offerings.

  • 5 Top Marijuana Stories of 2018
    Motley Fool5 days ago

    5 Top Marijuana Stories of 2018

    Here's what moved the needle in the biggest year ever for the marijuana industry.

  • GlobeNewswire6 days ago

    Constellation Brands to Report Third Quarter Fiscal 2019 Financial Results; Host Conference Call January 9, 2019

    VICTOR, N.Y., Dec. 05, 2018 -- Constellation Brands, Inc. (NYSE: STZ and STZ.B), a leading beverage alcohol company, announced today it will report financial results for its.

  • Brown-Forman (BF.B) Q2 Earnings Beat Estimates, Sales Miss
    Zacks6 days ago

    Brown-Forman (BF.B) Q2 Earnings Beat Estimates, Sales Miss

    Brown-Forman (BF.B) beats on second-quarter fiscal 2019 earnings while sales miss estimates. Results include impacts of tariff-related inventory reductions in the fiscal second quarter.